Cell Signaling Technology

Phospho-FAK (Tyr925) Antibody

#3284 · $150

100
Citing papers
13.7k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism9Glioma Diagnosis and Treatment8Cancer Cells and Metastasis7Cancer-related Molecular Pathways5Chemokine receptors and signaling5Cytokine Signaling Pathways and Interactions5Immune Cell Function and Interaction5Immune cells in cancer5

Papers citing this product

1
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
The Journal of Experimental Medicine·2011·797 cit.·DOI
2
Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis
Stem Cells·2005·676 cit.·DOI
3
Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy
Cell Death and Disease·2010·601 cit.·DOI
4
Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Journal of Clinical Investigation·2006·513 cit.·DOI
5
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Science·2021·443 cit.·DOI
6
MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction
The Journal of Cell Biology·2002·372 cit.·DOI
7
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Stem Cells·2010·317 cit.·DOI
8
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
Cell Death and Differentiation·2011·308 cit.·DOI
9
Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation
American Journal Of Pathology·2003·273 cit.·DOI
10
Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery
Journal of Extracellular Vesicles·2021·230 cit.·DOI
Phospho-FAK (Tyr925) Antibody — Evidence — PubIndex